CORRESP Filing
CytoDyn Inc.
Date: Nov. 26, 2025 · CIK: 0001175680 · Accession: 0001104659-25-116466
AI Filing Summary & Sentiment
File numbers found in text: 333-291263
Show Raw Text
CORRESP 1 filename1.htm November 26, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Lauren Hamill Re: CytoDyn Inc. Registration Statement on Form S-3 File No. 333-291263 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-3 filed on November 4, 2025 (Registration No. 333-291263) (the “Registration Statement”) so that the Registration Statement shall become effective at noon Eastern Time on December 2, 2025, or as soon as possible thereafter. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. Very truly yours, /s/ Robert E. Hoffman Robert E. Hoffman Chief Financial Officer